ImpriMed

Palo Alto, California, United States

Cancer Precision Medicine/Diagnostics Veterinary

ImpriMed provides cutting-edge personalized medicine easily accessible for pets with blood cancer diseases. ImpriMed’s key product, Chemo Response Prediction Service has been used by board-certified veterinary oncologists, helping over 2,000 dogs with lymphoma and leukemia. With ImpriMed’s services, veterinarians make their treatment decisions quickly and with confidence. This innovative approach to cancer care has been published in a scientific journal and presented at major conferences and is supported by over 150 veterinary oncologists at 80+ specialty hospitals in the US.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out ImpriMed on @MedStartr Today #Lymphoma #Leukemia #BloodDisorders #Cancer #PrecisionMedicineDiagnostics #Veterinary #MedMo #MedStartrVentures

https://www.medstartr.ai/s/dI6rxJTPO1U

Get Involved in ImpriMed

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2017
Website: www.imprimedicine.com/

Disease Areas

Lymphoma Leukemia Blood Disorders

Technologies

Personalized MedicinePredictive Analytics

🌐Website

What do you think of ImpriMed?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.